Key result
ECMO during unstable VT ablation linked to ~55% fewer subsequent ICD interventions.
Why the study?
Patients with fast ventricular tachycardia and electrical storm undergoing catheter ablation are at risk for cardiogenic shock, motivating the evaluation of extracorporeal membrane oxygenation support during ablation.
Does ECMO support during catheter ablation reduce arrhythmic burden and prevent acute procedural heart failure in patients with hemodynamically unstable ventricular arrhythmias?
Observational (n=62)
No
Does ECMO support during catheter ablation reduce arrhythmic burden and prevent acute procedural heart failure in patients with hemodynamically unstable ventricular arrhythmias?
Absolute Event Rate: 19% vs 42%
Prophylactic ECMO support during catheter ablation for hemodynamically unstable ventricular tachycardia allows for safe post-ablation inducibility testing and significantly reduces long-term arrhythmic burden.
ECMO support was associated with fewer ICD interventions in unstable VT ablation; hypothesis-generating and requires randomized confirmation.
Background: Catheter ablation is a treatment option for sustained ventricular tachycardias (VTs) that are refractory to pharmacological treatment; however, patients with fast VT and electrical storm (ES) are at risk for cardiogenic shock. We report our experience using cardiopulmonary support with extracorporeal membrane oxygenation (ECMO) during catheter ablation of VT. Methods: Sixty-two patients (mean age 68 ± 9 years; 94% male) were referred to our center for catheter ablation of repeated episodes of hemodynamically unstable ventricular arrhythmias. ES was defined as the occurrence of three or more VT/ventricular fibrillation episodes requiring electrical cardioversion or defibrillation in a 24-h period. All patients had hemodynamically unstable VTs. Results: Thirty-one patients (group 1) performed catheter ablation without ECMO support and 31 patients (group 2) with ECMO support. At the end of the procedure, ventricular inducibility was not performed in 16 patients of group 1 (52%) due to significant hemodynamic instability. Ventricular inducibility was performed in the other 15 patients (48%); polymorphic VTs were inducible in eight patients. In group 2, VTs were not inducible in 29 patients (93%); polymorphic VTs were inducible in two patients. The median follow-up duration was 24 months. Four patients of group 1 (13%) and five patients of group 2 (16%) died due to refractory heart failure. An implantable cardioverter-defibrillator intervention (shock or antitachycardia pacing) was documented in 13 patients of group 1 (42%) and six patients of group 2 (19%). Conclusions: Extracorporeal membrane oxygenation support during catheter ablation for hemodynamically unstable VTs is a useful tool to prevent acute procedural heart failure and to reduce arrhythmic burden.
No takes yet. Share an insight, caveat, or question.
Grimaldi et al. (2021) conducted an observational in Hemodynamically unstable ventricular arrhythmias (n=62). Extracorporeal membrane oxygenation (ECMO) during catheter ablation vs. Catheter ablation without ECMO support was evaluated on Implantable cardioverter-defibrillator intervention (shock or antitachycardia pacing). Extracorporeal membrane oxygenation support during catheter ablation for hemodynamically unstable VTs reduced subsequent ICD interventions (19% vs 42%) compared to ablation without ECMO.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: